Prognostic Factors and the Role of Pelvic Lymphadenectomy in Uterine Leiomyosarcomas

SAGE Open Medicine - United Kingdom
doi 10.1177/2050312119856817
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

SAGE Publications

Related search

Tailoring Pelvic Lymphadenectomy for Patients With Stage IA2, IB1, and IIA1 Uterine Cervical Cancer

Journal of Cancer
Oncology
2015English

Predictive and Prognostic Factors in Ovarian and Uterine Carcinosarcomas

Balkan Medical Journal
Medicine
2016English

Pulmonary Metastasectomy in Uterine Malignancy: Outcomes and Prognostic Factors

Journal of Thoracic Disease
PulmonaryRespiratory Medicine
2017English

Survival Analysis of Pelvic Lymphadenectomy Alone Versus Combined Pelvic and Para-Aortic Lymphadenectomy in Patients Exhibiting Endometrioid Type Endometrial Cancer

Oncology Letters
Cancer ResearchOncology
2014English

Staging Pelvic Lymphadenectomy for Prostatic Carcinoma

Japanese Journal of Urology
Urology
1993English

Robotic Modified Radical Hysterectomy With Pelvic Lymphadenectomy

ecancermedicalscience
Cancer ResearchOncology
2015English

Angiographic Embolization in the Treatment of Arterial Pelvic Hemorrhage: Evaluation of Prognostic Mortality-Related Factors

European Journal of Trauma and Emergency Surgery
Sports MedicineEmergency MedicineCritical CareOrthopedicsIntensive Care MedicineSurgery
2012English

The Laparoscopic Nervesparing Assisted Radical Vaginal Hysterectomy With Paraaortic and Pelvic Lymphadenectomy

JAPANESE JOURNAL OF GYNECOLOGIC AND OBSTETRIC ENDOSCOPY
2002English

Molecular and Immunohistochemical Evidence for the Origin of Uterine Leiomyosarcomas From Associated Leiomyoma and Symplastic Leiomyoma-Like Areas

Modern Pathology
Forensic MedicinePathology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy